Seeking Alpha

BioMarin (BMRN) gets added to William Blair's September Current Better Values list, saying its...

BioMarin (BMRN) gets added to William Blair's September Current Better Values list, saying its pipeline is one of the best in the industry. The company specializes in developing treatments for rare diseases and has a minimum of five drugs due to report various phase results before the end of the year. The most important of which is its BMN-110 Phase 3 data for the treatment of MPS IVA, a rare disease in which patients are missing the enzyme called galactose.
Comments (1)
  • QuantRec
    , contributor
    Comments (438) | Send Message
     
    Interesting will check it out. Looking for more biotech plays that are more stable.
    12 Sep 2012, 04:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|